Treatments

Electronic Interventions Show Promise for Pediatric Asthma, But Challenges Loom Large

By

Pulmonology Advisor Contributing Writer

Publish Date October 18, 2019

Researchers found data about the use of electronic interventions in asthma that were mixed in regards to efficacy and safety.

Rethinking the Safety of E-Cigarettes in Light of the Vaping Crisis

By

Tori Rodriguez, MA, LPC, AHC

Publish Date October 2, 2019

There has been ongoing controversy regarding the relative safety of e-cigarettes vs combustible cigarettes.

ATS Guideline on Microbiologic Testing for Diagnosing Pulmonary Fungal Infections

By

Brandon May

Publish Date October 2, 2019

The American Thoracic Society has published a new clinical practice guideline detailing recommendations for various microbiologic laboratory testing approaches for diagnosing fungal infections in pulmonary and critical care, with a particular focus on immunocompromised patients.

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

By

Steve Duffy

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.

Chest Tube Placement vs Needle Aspiration for Spontaneous Pneumothorax

By

Bryant Moeller

Both chest tube placement and needle aspiration were considered acceptable treatments for primary spontaneous pneumothorax.

NDA for Novel Amikacin Inhalation Submitted for Rare Lung Infection

By

Steve Duffy

ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product.

No Benefit From Prophylactic Antimicrobials in Aspiration Pneumonitis

By

Bradley van Paridon

Use of prophylactic antimicrobial therapy was not associated with a reduction in mortality or transfer to critical care compared with patients managed with supportive care only.

Drainage Duration, Length of Hospital Stay With Different Pneumothorax Treatments

By

Anna Kitabjian

Treatment with a small pigtail catheter may shorten the drainage duration and length of hospital stay in patients with spontaneous pneumothorax.

FDA Approves New CFTR Modulator Therapy for Cystic Fibrosis

By

Britt Gambino

A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.

Enteral vs Parenteral Nutrition in Critical Care Requiring Mechanical Ventilation

By

Laurel Ranger

Enteral nutritional support was not clinically superior to parenteral nutritional support in critically ill patients receiving mechanical ventilation.

Examining Compression-to-Ventilation Ratios for Optimal Neurologic, Survival Outcomes

By

Anna Kitabjian

Adults with cardiac arrest have better outcomes with continuous compressions with asynchronous ventilations or compression-to-ventilation ratios of 30:2.